Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winan J van Houdt

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Annals of Surgical Oncology|November 6, 2019
Margins in DFSP Reconsidered: Primum Non NocereWinan J van Houdt
Annals of Surgical Oncology|December 8, 2024
Sarcoma: Last Year's Practice Changing PapersWinan J van Houdt, Alessandro Gronchi
Annals of Surgical Oncology|October 16, 2022
ASO Author Reflections: Multimodality Treatment of Cutaneous AngiosarcomaSophie J M Reijers, Winan J van Houdt
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 9, 2022
Management of recurrent retroperitoneal sarcomasCaroline C H Siew, Kenneth Cardona, Winan J van Houdt
Annals of Surgical Oncology|October 15, 2023
ASO Author Reflections: The Role of Neoadjuvant Imatinib for GISTStijn J C van der Burg, Winan J van Houdt
Cancer|June 29, 2019
Reply to Follow-up after treatment of dermatofibrosarcoma protuberansEva A Huis In 't Veld, Winan J van Houdt
Eclinicalmedicine|February 28, 2023
Desmoid is not a sarcoma; reply to Sachdev et alWinette T A van der Graaf, Olga Husson, Winan J van Houdt
Annals of Surgical Oncology|March 22, 2017
Oncologic Outcome and Quality of Life After Hindquarter Amputation for Sarcoma: Is it Worth it?Winan J van Houdt, Anthony M Griffin, Jay S Wunder, et al.
Molecular Cancer Therapeutics|June 24, 2004
Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoterYosef S Haviv, Winan J van Houdt, Baogen Lu, et al.
Current Opinion in Oncology|March 21, 2019
New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaborationWinan J van Houdt, Chandrajit P Raut, Sylvie Bonvalot, et al.
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Annals of Surgical Oncology|November 6, 2019
Margins in DFSP Reconsidered: Primum Non NocereWinan J van Houdt
Annals of Surgical Oncology|December 8, 2024
Sarcoma: Last Year's Practice Changing PapersWinan J van Houdt, Alessandro Gronchi
Annals of Surgical Oncology|October 16, 2022
ASO Author Reflections: Multimodality Treatment of Cutaneous AngiosarcomaSophie J M Reijers, Winan J van Houdt
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 9, 2022
Management of recurrent retroperitoneal sarcomasCaroline C H Siew, Kenneth Cardona, Winan J van Houdt
Annals of Surgical Oncology|October 15, 2023
ASO Author Reflections: The Role of Neoadjuvant Imatinib for GISTStijn J C van der Burg, Winan J van Houdt
Cancer|June 29, 2019
Reply to Follow-up after treatment of dermatofibrosarcoma protuberansEva A Huis In 't Veld, Winan J van Houdt
Eclinicalmedicine|February 28, 2023
Desmoid is not a sarcoma; reply to Sachdev et alWinette T A van der Graaf, Olga Husson, Winan J van Houdt
Annals of Surgical Oncology|March 22, 2017
Oncologic Outcome and Quality of Life After Hindquarter Amputation for Sarcoma: Is it Worth it?Winan J van Houdt, Anthony M Griffin, Jay S Wunder, et al.
Molecular Cancer Therapeutics|June 24, 2004
Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoterYosef S Haviv, Winan J van Houdt, Baogen Lu, et al.
Current Opinion in Oncology|March 21, 2019
New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaborationWinan J van Houdt, Chandrajit P Raut, Sylvie Bonvalot, et al.
Pageof 17